/ INKT
/ Market Analysis
Why Did MiNK Therapeutics (INKT) Stock Jump 50% Premarket Today?
MiNK Therapeutics (INKT) surged in premarket trading after announcing a partnership with C-Further to develop a new pediatric cancer therapy.
March 10, 2026
Why Did INKT Stock Skyrocket in Today’s Premarket Trading?
MiNK Therapeutics stock surged 213% in premarket trading following the publication of a landmark case study showing complete cancer remission in a patient treated with their experimental therapy ...
July 11, 2025
Back to 
